New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For PPHM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 13, 2015
17:19 EDTPPHMPeregrine to highlight Bavituximab at ASCO annual meeting
Peregrine Pharmaceuticals, a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development, announced the presentation of three posters at the 2015 American Society of Clinical Oncology, ASCO, Annual Meeting, to be held May 29-June 2 in Chicago, Illinois.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use